SMTL ID : 9lq3.1

Crystal structure of Linafexor-FXR complex

Coordinates

PDB Format Compare

Method

X-RAY DIFFRACTION 2.80 Å

Oligo State

hetero-1-1-mer

Ligands

1 x 01: 3-[4-[(1~{S},5~{R})-3-[[3-[2,6-bis(chloranyl)phenyl]-5-cyclopropyl-1,2-oxazol-4-yl]methoxy]-8-azabicyclo[3.2.1]octan-8-yl]-2-fluoranyl-phenyl]-4~{H}-1,2,4-oxadiazol-5-one

01.1: 15 residues within 4Å: Chain A: M.22, L.44, T.45, M.47, A.48, M.85, F.86, R.88, S.89, L.105, Y.126, H.204, W.211, F.218, W.226 14 PLIP interactions: 14 interactions with chain A Hydrophobic interactions: A:L.44, A:L.44, A:M.47, A:A.48, A:M.85, A:F.86, A:F.86, A:F.86, A:R.88, A:L.105, A:W.211, A:F.218 Hydrogen bonds: A:M.22, A:R.88

Links

RCSB   PDBe   PDBe-KB   PDBj   PDBsum   CATH   PLIP

Citation

Yao, B. et al., Crystal structure of Linafexor-FXR complex. To Be Published

Release Date

2025-08-06

Peptides

Bile acid receptor: A
Nuclear receptor coactivator 2: B

SMTL:PDB

SMTL Chain Id:
PDB Chain Id:

A
A

B
C

Bile acid receptor

Nuclear receptor coactivator 2

Related Entries With Identical Sequence